{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T09:34:01Z","timestamp":1793093641641,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.ejmech.2019.04.034","type":"journal-article","created":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T02:43:57Z","timestamp":1555382637000},"page":"16-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Heterodimeric Rifampicin\u2013Tobramycin conjugates break intrinsic resistance of Pseudomonas aeruginosa to doxycycline and chloramphenicol in\u00a0vitro and in a Galleria mellonella in\u00a0vivo model"],"prefix":"10.1016","volume":"174","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1583-8562","authenticated-orcid":false,"given":"Temilolu","family":"Idowu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilbert","family":"Arthur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George G.","family":"Zhanel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8697-5519","authenticated-orcid":false,"given":"Frank","family":"Schweizer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2019.04.034_bib1","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1177\/003335491412900402","article-title":"Antibiotic resistance: a public health crisis","volume":"129","author":"Lushniak","year":"2014","journal-title":"Publ. Health Rep."},{"key":"10.1016\/j.ejmech.2019.04.034_bib2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/jac\/49.1.25","article-title":"Factors impacting on the problem of antibiotic resistance","volume":"49","author":"Levy","year":"2002","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2019.04.034_bib3","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.mib.2009.08.001","article-title":"The clinical consequences of antimicrobial resistance","volume":"12","author":"Rice","year":"2009","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.ejmech.2019.04.034_bib4","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.arcmed.2005.06.009","article-title":"Resistance to antibiotics: are we in the post-antibiotic era?","volume":"36","author":"Alanis","year":"2005","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.ejmech.2019.04.034_bib6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1128\/CMR.00030-10","article-title":"Challenges of antibacterial discovery","volume":"24","author":"Silver","year":"2011","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2019.04.034_bib7","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nrd3975","article-title":"Platforms for antibiotic discovery","volume":"12","author":"Lewis","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2019.04.034_bib10","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1128\/AAC.33.11.1831","article-title":"Outer membrane barrier as a mechanism of antimicrobial resistance","volume":"33","author":"Nikaido","year":"1989","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2019.04.034_bib11","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00077-17","article-title":"Antibiotic hybrids: the next generation of agents and adjuvants against gram-negative pathogens?","volume":"31","author":"Domalaon","year":"2018","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2019.04.034_bib12","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1021\/jm700967e","article-title":"Physicochemical properties of antibacterial compounds: implications for drug discovery","volume":"51","author":"O'Shea","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.04.034_bib13","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nature22308","article-title":"Predictive compound accumulation rules yield a broad-spectrum antibiotic","volume":"545","author":"Richter","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2019.04.034_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/595011","article-title":"Bad bugs, no drugs: no ESKAPE! an update from the Infectious Diseases Society of America","volume":"48","author":"Boucher","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2019.04.034_bib15","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.tim.2011.04.005","article-title":"Pseudomonas aeruginosa: all roads lead to resistance","volume":"19","author":"Breidenstein","year":"2011","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.ejmech.2019.04.034_bib16","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.mib.2016.05.005","article-title":"Treatment of gram-negative bacterial infections by potentiation of antibiotics","volume":"33","author":"Zabawa","year":"2016","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.ejmech.2019.04.034_bib17","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.tim.2016.06.009","article-title":"Antibiotic adjuvants: rescuing antibiotics from resistance","volume":"24","author":"Wright","year":"2016","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.ejmech.2019.04.034_bib18","doi-asserted-by":"crossref","first-page":"5929","DOI":"10.1021\/acs.jmedchem.5b01698","article-title":"Novel strategies for the treatment of Pseudomonas aeruginosa infections","volume":"59","author":"Wagner","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.04.034_bib19","doi-asserted-by":"crossref","first-page":"4420","DOI":"10.1128\/AAC.02536-13","article-title":"New amphiphilic neamine derivatives active against resistant Pseudomonas aeruginosa and their interactions with lipopolysaccharides","volume":"58","author":"Sautrey","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2019.04.034_bib20","doi-asserted-by":"crossref","first-page":"e00200","DOI":"10.1128\/AAC.00200-17","article-title":"Potentiation of antibiotic activity by a novel cationic peptide: potency and spectrum of activity of SPR741","volume":"61","author":"Corbett","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2019.04.034_bib21","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/anie.201508330","article-title":"Adjuvants based on hybrid antibiotics overcome resistance in Pseudomonas aeruginosa and enhance fluoroquinolone efficacy","volume":"55","author":"Gorityala","year":"2016","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.ejmech.2019.04.034_bib22","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/jac\/8.4.249","article-title":"Aminoglycoside uptake and mode of action \u2013 with special reference to streptomycin and gentamicin. I. Antagonists and mutants","volume":"8","author":"Hancock","year":"1981","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2019.04.034_bib23","doi-asserted-by":"crossref","first-page":"6645","DOI":"10.1021\/acs.jmedchem.6b00485","article-title":"Development of a dual-acting antibacterial agent (TNP-2092) for the treatment of persistent bacterial infections","volume":"59","author":"Ma","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.04.034_bib24","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/ja.2014.107","article-title":"Resistance to rifampicin: a review","volume":"67","author":"Goldstein","year":"2014","journal-title":"J.\u00a0Antibiot. (Tokyo)"},{"key":"10.1016\/j.ejmech.2019.04.034_bib25","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1021\/acs.jmedchem.6b01742","article-title":"Amphiphilic tobramycin\u2212lysine conjugates sensitize multidrug resistant gram-negative bacteria to rifampicin and minocycline","volume":"60","author":"Lyu","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.04.034_bib26","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.ejmech.2019.04.034_bib27","doi-asserted-by":"crossref","first-page":"6278","DOI":"10.1002\/anie.201500598","article-title":"Amphiphilic tobramycins with immunomodulatory properties","volume":"54","author":"Guchhait","year":"2015","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.ejmech.2019.04.034_bib28","doi-asserted-by":"crossref","first-page":"8441","DOI":"10.1021\/acs.jmedchem.6b00867","article-title":"Hybrid antibiotic overcomes resistance in P. aeruginosa by enhancing outer membrane penetration and reducing Efflux","volume":"59","author":"Gorityala","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.04.034_bib29","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0092-8674(01)00286-0","article-title":"Structural mechanism for rifampicin inhibition of bacterial RNA polymerase","volume":"104","author":"Campbell","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2019.04.034_bib30","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1002\/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4","article-title":"A\u00a0stepwise huisgen cycloaddition process: copper(I)-Catalyzed regioselective \u201cligation\u201d of azides and terminal alkynes","volume":"41","author":"Rostovtsev","year":"2002","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2019.04.034_bib31","doi-asserted-by":"crossref","first-page":"9779","DOI":"10.1021\/acs.jmedchem.5b01578","article-title":"Synthesis of tridecaptin-antibiotic conjugates with in\u00a0vivo activity against gram-negative bacteria","volume":"58","author":"Cochrane","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.04.034_bib32","series-title":"CLSI Supplement M100","article-title":"Performance standards for antimicrobial susceptibility testing","year":"2017"},{"key":"10.1016\/j.ejmech.2019.04.034_bib33","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2323\/jgam.47.27","article-title":"Roles of MexXY- and MexAB-multidrug efflux pumps in intrinsic multidrug resistance of Pseudomonas aeruginosa PAO1","volume":"47","author":"Morita","year":"2001","journal-title":"J.\u00a0Gen. Appl. Microbiol."},{"key":"10.1016\/j.ejmech.2019.04.034_bib34","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1128\/AAC.45.1.105-116.2001","article-title":"Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa\u202f: novel agents for combination therapy","volume":"45","author":"Lomovskaya","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2019.04.034_bib35","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1128\/AAC.00440-06","article-title":"Method for regulated expression of single-copy efflux pump genes in a surrogate Pseudomonas aeruginosa strain: identification of the BpeEF-OprC chloramphenicol and trimethoprim efflux pump of Burkholderia pseudomallei 1026b","volume":"50","author":"Kumar","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2019.04.034_bib36","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1128\/AAC.38.8.1732","article-title":"Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: resistance to tetracycline, chloramphenicol, and norfloxacin","volume":"38","author":"Li","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2019.04.034_bib37","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/jac\/dki291","article-title":"Tigecycline: what is it, and where should it be used?","volume":"56","author":"Livermore","year":"2005","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2019.04.034_bib38","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1128\/AAC.47.3.972-978.2003","article-title":"Efflux-mediated resistance to tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1","volume":"47","author":"Dean","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2019.04.034_bib39","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1093\/cid\/cix1127","article-title":"Busting the myth of \u201cstatic vs cidal\u201d: a systemic literature review","volume":"66","author":"Wald-Dickler","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2019.04.034_bib40","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ijantimicag.2010.10.031","article-title":"Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay","volume":"37","author":"Pournaras","year":"2011","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejmech.2019.04.034_bib41","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1128\/CMR.05041-11","article-title":"Combination therapy for treatment of infections with gram-negative bacteria","volume":"25","author":"Tamma","year":"2012","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2019.04.034_bib42","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1099\/jmm.0.074245-0","article-title":"A\u00a0Galleria mellonella infection model reveals double and triple antibiotic combination therapies with enhanced efficacy versus a multidrug-resistant strain of Pseudomonas aeruginosa","volume":"63","author":"Krezdorn","year":"2014","journal-title":"J.\u00a0Med. Microbiol."},{"key":"10.1016\/j.ejmech.2019.04.034_bib43","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ijantimicag.2013.11.001","article-title":"Evaluation of Galleria mellonella larvae for measuring the efficacy and pharmacokinetics of antibiotic therapies against Pseudomonas aeruginosa infection","volume":"43","author":"Hill","year":"2014","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejmech.2019.04.034_bib44","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01239-17","article-title":"SPR741, an antibiotic adjuvant, potentiates the in\u00a0vitro and in\u00a0vivo activity of rifampin against clinically relevant extensively drug-resistant acinetobacter baumannii","volume":"61","author":"Zurawski","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2019.04.034_bib45","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/antibiotics6040026","article-title":"Ubiquitous nature of fluoroquinolones: the oscillation between antibacterial and anticancer activities","volume":"6","author":"Idowu","year":"2017","journal-title":"Antibiotics"},{"key":"10.1016\/j.ejmech.2019.04.034_bib46","doi-asserted-by":"crossref","first-page":"9724","DOI":"10.1021\/acs.jmedchem.7b01198","article-title":"Amphiphilic modulation of glycosylated antitumor ether lipids results in a potent triamino scaffold against epithelial cancer cell lines and BT474 cancer stem cells","volume":"60","author":"Idowu","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.04.034_bib47","doi-asserted-by":"crossref","first-page":"5652","DOI":"10.1002\/anie.201200761","article-title":"6\u2033-thioether tobramycin analogues: towards selective targeting of bacterial membranes","volume":"51","author":"Herzog","year":"2012","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2019.04.034_bib48","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1128\/MMBR.65.2.232-260.2001","article-title":"Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance","volume":"65","author":"Chopra","year":"2001","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.ejmech.2019.04.034_bib49","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1021\/acsinfecdis.8b00078","article-title":"Derivatives of ribosome-inhibiting antibiotic chloramphenicol inhibit the biosynthesis of bacterial cell wall","volume":"4","author":"Louzoun Zada","year":"2018","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2019.04.034_bib50","doi-asserted-by":"crossref","first-page":"796","DOI":"10.15252\/msb.20145949","article-title":"Growth-dependent bacterial susceptibility to ribosome-targeting antibiotics","volume":"11","author":"Greulich","year":"2015","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.ejmech.2019.04.034_bib51","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/nchembio.559","article-title":"Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy","volume":"7","author":"Ejim","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2019.04.034_bib52","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1080\/21505594.2015.1135289","article-title":"Galleria mellonella infection models for the study of bacterial diseases and for antimicrobial drug testing","volume":"7","author":"Tsai","year":"2016","journal-title":"Virulence"},{"key":"10.1016\/j.ejmech.2019.04.034_bib53","doi-asserted-by":"crossref","first-page":"7691","DOI":"10.1021\/jm401148j","article-title":"Tuning the antibacterial activity of amphiphilic neamine derivatives and comparison to paromamine homologues","volume":"56","author":"Zimmermann","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.04.034_bib54","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1128\/AAC.01538-07","article-title":"Antimicrobial-resistant pathogens in intensive care units in Canada: results of the canadian national intensive care unit (CAN-ICU) study, 2005-2006","volume":"52","author":"Zhanel","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"issue":"Suppl 1","key":"10.1016\/j.ejmech.2019.04.034_bib55","doi-asserted-by":"crossref","first-page":"i7","DOI":"10.1093\/jac\/dkt022","article-title":"Antimicrobial susceptibility of 22746 pathogens from Canadian hospitals: results of the CANWARD 2007-11 study","volume":"68","author":"Zhanel","year":"2013","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2019.04.034_bib56","doi-asserted-by":"crossref","first-page":"4684","DOI":"10.1128\/AAC.00469-10","article-title":"Prevalence of antimicrobial-resistant pathogens in canadian hospitals: results of the canadian ward surveillance study (CANWARD 2008)","volume":"54","author":"Zhanel","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2019.04.034_bib57","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.chemphyslip.2015.07.003","article-title":"Design, synthesis and antitumor properties of glycosylated antitumor ether lipid (GAEL)-chlorambucil-hybrids","volume":"194","author":"Idowu","year":"2016","journal-title":"Chem. Phys. Lipids"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419303496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419303496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:52:13Z","timestamp":1759326733000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523419303496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":54,"alternative-id":["S0223523419303496"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.04.034","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heterodimeric Rifampicin\u2013Tobramycin conjugates break intrinsic resistance of Pseudomonas aeruginosa to doxycycline and chloramphenicol in\u00a0vitro and in a Galleria mellonella in\u00a0vivo model","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.04.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}